Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes.
João CoelhoLuísa MalheiroJoão Melo BeirãoAngelina MeirelesBernardete PessoaPublished in: Clinical ophthalmology (Auckland, N.Z.) (2019)
This real-world study demonstrates long-term effectiveness of FAc in vitrectomized DME eyes and sustained effectiveness in DME eyes that did not respond to DEX therapy.